{"The claim states that": "big pharmaceuticals pay off generics to keep the prices and the competition off the market.\" The expert's verdict confirms that pharmaceutical companies do compensate generic competitors to delay marketing their versions of brand-name drugs, resulting in delays before cheaper, generic drugs become available.", "The expert": "s verdict mentions a specific example of pay-for-delay allegations involving the drug Humira. AbbVie, the manufacturer of Humira, has been accused of engaging in pay-for-delay deals to protect its claim on the drug. While the details of these settlements are confidential, AbbVie has publicly denied using pay-for-delay tactics with Humira."}